Cited 4 times in
Comparison of 2-Stenting Strategies Depending on Sequence or Technique for Bifurcation Lesions in the Second-Generation Drug-Eluting Stent Era - Analysis From the COBIS (Coronary Bifurcation Stenting) III Registry
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 홍명기 | - |
dc.date.accessioned | 2022-11-24T00:30:57Z | - |
dc.date.available | 2022-11-24T00:30:57Z | - |
dc.date.issued | 2021-10 | - |
dc.identifier.issn | 1346-9843 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/190733 | - |
dc.description.abstract | Background: It has not been determined which specific 2-stenting strategy is the best for bifurcation lesions. Our aim was to investigate the clinical outcomes of various 2-stenting strategies in the era of 2nd-generation drug-eluting stents (2G-DES).Methods and Results:We analyzed 454 patients who finally underwent 2-stenting for a bifurcation lesion, from among 2,648 patients enrolled in the COBIS III registry. The primary outcome was target lesion failure (TLF). Patients were analyzed according to stenting sequence (provisional [main vessel stenting first] vs. systemic [side branch stenting first]) and stenting technique (crush vs. T vs. culotte vs. kissing/V stenting). Overall, 4.4 years' TLF after 2-stenting treatment for bifurcation lesion was excellent: TLF 11.2% and stent thrombosis 1.3%. There was no difference in TLF according to 2-stenting strategy (11.1% vs. 10.5%, P=0.990 for provisional and systemic sequence; 8.6% vs. 14.4% vs. 12.9% vs. 12.2%, P=0.326 for crush, T, culotte, kissing/V technique, respectively). Only left main (LM) disease and a shorter duration of dual antiplatelet therapy (DAPT) were associated with TLF. The distribution of DAPT duration differed between patients with and without TLF, and the time-point of intersection was 2.5 years. Also, the side branch was the most common site of restenosis. Conclusions: The stenting sequence or technique did not affect clinical outcomes, but LM disease and shorter DAPT were associated with TLF, in patients with bifurcation lesions undergoing 2-stenting with 2G-DES. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.language | English, Japanese | - |
dc.publisher | Japanese Circulation Society | - |
dc.relation.isPartOf | CIRCULATION JOURNAL | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Coronary Artery Disease* / drug therapy | - |
dc.subject.MESH | Drug-Eluting Stents* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Platelet Aggregation Inhibitors / therapeutic use | - |
dc.subject.MESH | Registries | - |
dc.subject.MESH | Treatment Outcome | - |
dc.title | Comparison of 2-Stenting Strategies Depending on Sequence or Technique for Bifurcation Lesions in the Second-Generation Drug-Eluting Stent Era - Analysis From the COBIS (Coronary Bifurcation Stenting) III Registry | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Jeehoon Kang | - |
dc.contributor.googleauthor | Jung-Kyu Han | - |
dc.contributor.googleauthor | Han-Mo Yang | - |
dc.contributor.googleauthor | Kyung Woo Park | - |
dc.contributor.googleauthor | Hyun-Jae Kang | - |
dc.contributor.googleauthor | Hyeon-Cheol Gwon | - |
dc.contributor.googleauthor | Woo Jung Chun | - |
dc.contributor.googleauthor | Seung-Ho Hur | - |
dc.contributor.googleauthor | Seung Hwan Han | - |
dc.contributor.googleauthor | Seung-Woon Rha | - |
dc.contributor.googleauthor | In-Ho Chae | - |
dc.contributor.googleauthor | Jin-Ok Jeong | - |
dc.contributor.googleauthor | Jung Ho Heo | - |
dc.contributor.googleauthor | Junghan Yoon | - |
dc.contributor.googleauthor | Do-Sun Lim | - |
dc.contributor.googleauthor | Jong-Seon Park | - |
dc.contributor.googleauthor | Myeong-Ki Hong | - |
dc.contributor.googleauthor | Joon-Hyung Doh | - |
dc.contributor.googleauthor | Kwang Soo Cha | - |
dc.contributor.googleauthor | Doo-Il Kim | - |
dc.contributor.googleauthor | Sang Yeub Lee | - |
dc.contributor.googleauthor | Kiyuk Chang | - |
dc.contributor.googleauthor | Byung-Hee Hwang | - |
dc.contributor.googleauthor | So-Yeon Choi | - |
dc.contributor.googleauthor | Myung Ho Jeong | - |
dc.contributor.googleauthor | Young Bin Song | - |
dc.contributor.googleauthor | Ki Hong Choi | - |
dc.contributor.googleauthor | Soon-Jun Hong | - |
dc.contributor.googleauthor | Chang-Wook Nam | - |
dc.contributor.googleauthor | Bon-Kwon Koo | - |
dc.contributor.googleauthor | Hyo-Soo Kim | - |
dc.identifier.doi | 10.1253/circj.CJ-20-0999 | - |
dc.contributor.localId | A04391 | - |
dc.relation.journalcode | J00534 | - |
dc.identifier.eissn | 1347-4820 | - |
dc.identifier.pmid | 34078776 | - |
dc.subject.keyword | 2-stenting technique | - |
dc.subject.keyword | Adjunctive pharmacotherapy | - |
dc.subject.keyword | Bifurcation | - |
dc.subject.keyword | Drug-eluting stents | - |
dc.subject.keyword | Left main disease | - |
dc.contributor.alternativeName | Hong, Myeong Ki | - |
dc.contributor.affiliatedAuthor | 홍명기 | - |
dc.citation.volume | 85 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 1944 | - |
dc.citation.endPage | 1955 | - |
dc.identifier.bibliographicCitation | CIRCULATION JOURNAL, Vol.85(11) : 1944-1955, 2021-10 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.